At Nexstride, our purpose drives us. Our founder, Sidney Collin, began her project based on one veteran Parkinson's patient's pain-points — freezing of gait (FoG). The initial prototype of the mobility device brought tremendous relief and made walking easier than before. Sidney then knew that the product she was designing had greater potential and could help other Parkinson's patients trembling in their steps to take the next step. This realization marked the beginning of De Oro Devices — the parent company of NexStride.
Our team then began pouring hours and hours of work refining today's NexStride. Our efforts have been recognized at various conferences and competitions, which only boosts our morale and lifts us to better the mobility device for our customers and all patients who experience Freezing of gait or Parkinsonian gait.
We won first place at the 2019 BIOMEDevice StartUp Pitch Competition. This is our more recent win and we’re so proud of it.
Participating in Angel Conference was an invaluable experience. Winning the first prize gave necessary funding. Such an important win this one was!
Early in our NexStride journey we picked the Elevator Pitch First Place and the Marjorie and James Sly Innovation award. This recognition showed us we were on the right track.
NexStride began with a Cal Poly State University, San Luis Obispo project. Challenged to create a tool that would alleviate and prevent freezing of gait in a local veteran, our simple prototype gave him much needed relief. We soon realized the global potential for our product.
Our team at De Oro Devices has spent countless hours researching and refining NexStride so that it is intuitive to use and blends seamlessly into daily life, ensuring optimal impact with minimal intrusion.
The treatment of Freezing of gait (FoG) or Parkinsonian gait through cueing could offer a breakthrough in helping people with Parkinson’s recover their independence, restore their motor ability, and increase confidence. Sensory and auditory cueing could be the key to assisting people from experiencing this debilitating symptom.